Aethlon Medical, Inc. earnings releases AEMD

Aethlon Medical, Inc. last reported quarterly results on Aug 13, 2026, for Q1 FY2027 (the quarter ended Jun 30, 2026): diluted EPS of -$4.02. It usually reports 43–71 days after a quarter ends. Based on that pattern, the next release is estimated for around Nov 11, 2026.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 43–71 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released Quarter Revenue Net income Diluted EPS
Aug 13, 2026
44 days after quarter end
Q1 FY2027
ended Jun 30, 2026
—
-2
+12.1%
-4.02
+90.5%
Jun 10, 2026
71 days after quarter end
Q4 FY2026
ended Mar 31, 2026
—
-2
+69.9%
-1.48
+95.7%
Feb 12, 2026
43 days after quarter end
Q3 FY2026
ended Dec 31, 2025
—
-2
-15.0%
-2.45
+75.6%
Nov 12, 2025
43 days after quarter end
Q2 FY2026
ended Sep 30, 2025
—
-1
+47.0%
-3.74
+76.8%
Aug 13, 2025
44 days after quarter end
Q1 FY2026
ended Jun 30, 2025
—
-2
+31.5%
-42.42
-1437.0%
Feb 12, 2025
43 days after quarter end
Q3 FY2025
ended Dec 31, 2024
—
-2
+49.4%
-10.05
-633.6%
Nov 13, 2024
44 days after quarter end
Q2 FY2025
ended Sep 30, 2024
—
-3
+7.5%
-16.11
-1220.5%
Aug 14, 2024
45 days after quarter end
—
ended Jun 30, 2024
—
—
—

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
AEMD (Nasdaq)
Fiscal year ends
March 31
Incorporated in
NV
Headquarters
San Diego, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
882291
Former names
BISHOP EQUITIES INC (until Mar 13, 2000)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.